trending Market Intelligence /marketintelligence/en/news-insights/trending/iMVQrYX4oy2IqIlKTcF2RQ2 content esgSubNav
In This List

Kurma Partners seeks €150M for biotechnology fund

Podcast

Street Talk | Episode 94: Recessionary fears in '22 overblown, Fed could overtighten

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Kurma Partners seeks €150M for biotechnology fund

Paris-based venture capital firm Kurma Partners, which backs early-stage life sciences companies in Europe, held a first close for Kurma Biofund III.

The fund has a final closing target of €150 million. It will invest in about 12 to 15 private companies, four to five of which will be established by Kurma.

Pharmaceutical company Servier, French national investment bank Bpifrance SA and European midmarket private equity and venture capital firm Idinvest Partners SA, as cornerstone investors, will join the fund's advisory committee. Other institutional investors and family offices also participated in the fund's first closing.